SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins the later rounds of HAX and IndieBio graduates.  HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

SOSV

Texas HALO Fund is an investment company that specializes in investing in early-stage businesses with promising growth prospects and exceptional management teams. Its investment approach identifies compelling businesses from multiple sources and without regard to the industry or geographic location.  Quite simply, it seeks the best opportunities, locally, regionally, and nationally, in order to generate the highest returns for the investors with the lowest possible risk. The firm was founded in 2012 and is headquartered in Houston, Texas.

Texas HALO Fund

Megaforce is a premier Electronics Manufacturing Services company.

Megaforce

We are a multi-faceted platform that provides high-quality solutions on a marketplace, product distribution & localisation support and B2B consulting. Since its founding in 2019, we have built partnerships with international femtech hubs and established a network of over 2,000 companies worldwide with an aim to improve a woman's quality of life. Our global team's expertise span across public health, community development and various industry fields which has contributed to the growth of the company and our reputation of being a femtech thought leader in Asia.

fermata

Berkeley Angel Network is a venture capital and private equity firm that specializes in the fields of finance and investment management. Its mission of the Berkeley Angel Network is to build an angel investor community among the alumni and faculty of UC Berkeley and to improve the collective skills and knowledge of this angel investor community through activities related to angel investing.

Berkeley Angel Network

HAX is a venture capital-based program dedicated to accelerating startups with a hardware element. Their program operates across two locations, San Francisco and Shenzhen, giving founders the resources necessary to move with lightning speed. Teams accepted into the program will focus on rapid iteration of prototyping in many forms. This includes physical models, technology iterations, user interaction studies, volumetric studies, marketing messaging, business plans and launch strategies. With the help of HAX’s full-time staff, mentors, partners, and startup community, they’ll also work with you on developing a scalable business plan. As teams are ready to take their  product to market, they’ll head to San Francisco to work with HAX on business development, fundraising, and growth. This stage emphasizes introductions to corporates, investors, partners and press. It also focuses on helping teams secure their first round of funding, as well as gain first-revenue and partnership traction. HAX is an SOSV program. SOSV is a global venture capital firm that operates startup venture programs around the world. SOSV had more than 1,000 portfolio companies and $950 million in assets under management.

For Good Ventures is an investment firm that supports innovative, disruptive technologies changing the world for good. The firm invests in for-profit, positive-impact businesses, and funds in private markets positioned for scalable, positive change. It specifically invests in companies that fundamentally benefit humanity or the environment as a core focus of their business model.

For Good Ventures

Ad Astra Ventures is an investment firm with an exclusive focus on women-led innovations. The firm is on a mission to equip female entrepreneurs to build, run, and scale investable businesses. Its program is specifically designed to empower founders who are impacted by implicit gender biases. Ad Astra Ventures' framework provides entrepreneurs with the tools to combat these biases through introspection, exploration, and simulations. Ad Astra Ventures was founded in 2018 and is based in Solana Beach, California.

Ad Astra Ventures

Althea is an early-stage venture fund with a track record of significant value creation. They have a unique global network spanning finance, academia, public corporations, and start-up operators that enables them to identify, invest in, and grow mission-driven, tenacious founding teams.

Althea Ventures

kegg

Kegg is a two-in-one device that combines fertility tracking with pelvic floor exercising. Lady Technologies is implementing sensing technology into consumer devices to advance women's health. Its first product, kegg, is an intuitive fertility tracker that quadruples the chances of natural conception by detecting the fertile window and ovulation up to 7 days in advance. Kegg collects the previously unattainable data from cervical fluid, which is essential for the better diagnosis, monitoring, and treatment of women. The company was founded in 2017 and based in San Francisco, California.

Kegg offers an at-home fertility measurement kit through a vaginally inserted egg-shaped device that measures hormonal changes in a woman’s cervical fluid. The device is considered a two-in-one device; it combines fertility tracking with pelvic floor exercising. The device’s daily use enables accurate cycle tracking.

Long-term demographic changes are finally bringing fertility technologies into focus.

Fertility Tech

Kegg

Kegg Unveils Study Showing Potential for Hormone-Free Birth Control Through Cervical Fluid Tracking

Kegg offers an at-home fertility measurement kit through a vaginally inserted egg-shaped device that measures hormonal changes in a woman’s cervical fluid. The device is considered a two-in-one device; it combines fertility tracking with pelvic floor exercising. The device’s daily use enables accurate cycle tracking.Kegg devices are smartphone compatible for sharing of data which is uploaded to the cloud for algorithmic analysis. Kegg launched its product out of beta testing in October 2020, and currently charges a fixed price of USD 275 for the device; however, intends to offer subscription packages in the future.In September 2021, the company raised USD 3 million in a seed funding round led by Crescent Ridge Partners. The company expects to use the funding to invest in its pelvic floor exercise technology, to conduct cervical fluid testing, expand pilot testing, research partnerships, and provide services to the perimenopause, menopause, postpartum, and infections segments.

<div>
 
 Glow offers apps that track data related to women’s fertility including ovulation cycle and pregnancy tracking. In addition to apps, the company also offers individualized fertility coaching, clinic identification and community support, and links patients with clinics for procedures such as egg freezing. 
 
 
 Glow generated around USD 0.3 million monthly revenue in October 2020, and as of February 2019 it had around 15 million users, and claims to have helped about 950,000 women get pregnant (from May 2013 to February 2019). In February 2019 Glow partnered with US Match Group (provider of dating products such as Match.com and Tinder), to provide Match’s employees with egg freezing benefits at reputed fertility clinics. In May 2017 it partnered with the National Institute of Health (NIH) to update a prediction model for couples trying to conceive.  
 
 
 In 2020, the company faced investigations into privacy and security failures involving its app. Glow agreed to pay a USD 0.25 million settlement in September 2020.
 
 
 
</div>

Glow

<div>
 
 Inne, based in Germany, offers an at-home mini lab kit for women. Hormone analysis is conducted based on saliva samples. The lab device connects to smartphones for storage and access to the analysis results.
 
 
 Unlike peer offerings, Inne does not attempt to predict future cycles and fertility dates, and instead educates users about their bodies, with information on what changes they should feel in response to the hormonal levels on the day.
 
 
 In May 2022, Inne 
 <a href="https://sp-edge.com/updates/10667?industryIds=40">
 raised USD 10 million
 </a>
 in an extension to its Series A round led by DSM Venturing. The company utilized the funds to continue the development of its mini lab and platform, grow its team, and support its expansion across the US, where it aims to enter with its perimenopause feature, followed by an expanded product launch in late 2022.
 
 
 
</div>

Inne

Proov (formerly known as MFB Fertility) offers the at-home “Proov'' ovulation and progesterone test. Proov tracks hormone levels in urine over multiple days, after suspected ovulation, and estimates whether the progesterone levels are sufficient for implantation, during the 7-10 day implantation window.As of May 2021, it was the only FDA-cleared urine PdG (urine metabolite of the progesterone hormone) test, and its method of determining the fertile window was patented. Moreover, it received the CE marking and expanded its sales footprint to Europe in June 2021.In June 2020, the company received a USD 1.3 million deal from the US Air Force, to provide Proov kits to enrolled individuals. The Proov test was distributed through leading US retailers such as Target and Amazon, and was also used by doctors across the country.Proov raised USD 9.7 million in Series A funding in December 2021, in a round led by Hambrecht Ducera Growth Ventures, with participation from other venture capital firms such as SteelSky Ventures, WCC Partners, and Lightship Capital, among others. The company expects to use the funding to grow its “Complete” product, which includes follicle-stimulating hormone tests and other multi-hormone tests that measure estrone glucuronide, LH and PdG.

Proov

<div>
 
 Progyny works with employers (primarily large enterprises in the US) to optimize the fertility benefits they offer for their employees. It connects employees to fertility specialists and clinics, and also offers extensive support to patients through their Progyny Patient Care Advocates, who provide clinical guidance, education, and emotional support.
 
 
 The company was founded as a fertility education platform and eventually included in vitro fertilization (IVF) referral network Fertility Authority and reproductive health company Auxogyn, into its network. The company pivoted into offering fertility benefit solutions in 2016, and launched Progyny Rx (fertility medication benefit) in 2018.
 
 
 Progyny connects patients to a network of 800 fertility specialists and nearly 600 clinic locations.&nbsp;
 
 
 Key customers and partnerships
 
 
 As of March 2022, the company served 264 enterprise customers (including Facebook, Microsoft, Google, and Nasdaq), and had 3.9 million active members.
 
 
 Funding and financials
 
 
 In October 2019, Progyny raised USD 130 million through its IPO, where it was listed on the Nasdaq.
 
 
 In FY2021, the company reported a revenue of USD 500.6 million reflecting a 45% YoY growth and a net income of USD 65.8 million. The company&rsquo;s revenue for 
 <a href="https://sp-edge.com/updates/14396">
 Q3 FY2022
 </a>
 amounted to USD 205.4 million, representing 68% YoY growth. The management&rsquo;s revenue guidance for FY2022 ranges between USD 775 million and USD 785 million, which implies an YoY growth of 55% to 57%.
 
</div>

Progyny

<div>
 
 Prima Temp offers the artificial intelligence (AI) assisted “Priya” intarvaginal ring sensor and accompanying app to continuously measure a woman’s core body temperature, predicting fertility windows. The app uses big data to improve its predictions, and the app notifies the user of fertile windows. The company also offers the “Kindara” fertility tracking app, which provides fertility related education and links users to a community of over 140,000 members.  
 
 
 The company raised USD 5 million in funding in May 2019 from Gedeon Richter, a Hungarian pharmaceutical company. Although the company primarily focuses on fertility monitoring, it intends to expand its offerings to include other areas of fertility management such as contraception and menopause.  
 
 
 
 
 
</div>

Prima Temp

Test kits which use saliva, blood, or temperature to determine hormone levels and form conclusions on fertility and fertility cycles.


Apps which use data science to identify fertility windows.

Organizations that freeze eggs or embryos for usage at a future date.


Services that analyze sperm samples (via test kit) and/or offer storage facilities for future use.

Companies specializing in supporting patient decision making, financing, clinical visits, physician referrals, and at-home treatments

Offers digital platforms and apps to provide fertility-related support

Uses AI/ML to improve cycle predictions and track symptoms

Some startups use genetic screening to tailor treatment or identify underlying issues

Kegg

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless